OPN1MW2

gene
On this page

Summary

OPN1MW2 (opsin 1, medium wave sensitive 2, HGNC:26952) is a protein-coding gene on chromosome Xq28, encoding Medium-wave-sensitive opsin 2 (P0DN77). Visual pigments are the light-absorbing molecules that mediate vision.

This gene encodes for a light absorbing visual pigment of the opsin gene family. The encoded protein is called green cone photopigment or medium-wavelength sensitive opsin. Opsins are G-protein coupled receptors with seven transmembrane domains, an N-terminal extracellular domain, and a C-terminal cytoplasmic domain. The long-wavelength opsin gene and multiple copies of the medium-wavelength opsin gene are tandemly arrayed on the X chromosome and frequent unequal recombination and gene conversion may occur between these sequences. X chromosomes may have fusions of the medium- and long-wavelength opsin genes or may have more than one copy of these genes. Defects in this gene are the cause of deutanopic colorblindness.

Source: NCBI Gene 728458 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 30 total — 3 pathogenic
  • MANE Select transcript: NM_001048181

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26952
Approved symbolOPN1MW2
Nameopsin 1, medium wave sensitive 2
LocationXq28
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000166160
Ensembl biotypeprotein_coding
Entrez728458

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000369929, ENST00000430419, ENST00000488220

RefSeq mRNA: 1 — MANE Select: NM_001048181 NM_001048181

CCDS: CCDS35447

Canonical transcript exons

ENST00000369929 — 6 exons

ExonStartEnd
ENSE00001775155154230548154230787
ENSE00001804493154228828154228993
ENSE00001836079154233070154233286
ENSE00001937441154219756154219927
ENSE00003569555154224908154225204
ENSE00003664302154227192154227360

Expression profiles

Bgee: expression breadth tissue_specific, 4 present calls, max score 46.18.

Top tissues by expression

106 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099146.18silver quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
vermiform appendixUBERON:000115435.62silver quality
ganglionic eminenceUBERON:000402335.49gold quality
bone marrowUBERON:000237135.06gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
muscle tissueUBERON:000238532.44gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
sural nerveUBERON:001548830.93gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.35gold quality
smooth muscle tissueUBERON:000113528.73silver quality
liverUBERON:000210728.57gold quality
duodenumUBERON:000211428.14gold quality
urinary bladderUBERON:000125527.65gold quality
lymph nodeUBERON:000002927.57gold quality
tonsilUBERON:000237227.05gold quality
skin of legUBERON:000151126.62silver quality
islet of LangerhansUBERON:000000626.55gold quality
muscle of legUBERON:000138326.53gold quality
gall bladderUBERON:000211025.98gold quality
zone of skinUBERON:000001425.96silver quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
gastrocnemiusUBERON:000138825.60gold quality
leukocyteCL:000073825.26gold quality
monocyteCL:000057625.03gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

13 targeting OPN1MW2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-453499.9966.581907
HSA-MIR-96-5P99.9572.802140
HSA-MIR-1213399.9271.822006
HSA-MIR-1271-5P99.9171.991972
HSA-MIR-182-5P99.8774.032589
HSA-MIR-57799.7869.132479
HSA-MIR-6794-5P99.7666.381048
HSA-MIR-4716-3P99.6966.731022
HSA-MIR-472999.6972.184233
HSA-MIR-451699.6167.783390
HSA-MIR-570399.1067.092053
HSA-MIR-443499.1067.011984
HSA-MIR-625-5P99.0268.642031

Literature-anchored findings (GeneRIF, showing 1)

  • Immunoreactivity to anti-OPN1LW antibodies was seen in the basal layer of human epidermis & reconstructed skin. The opsin mRNA was seen in total RNA from human skin. Neither immunoreactivity nor mRNA expression was seen in cultured human keratinocytes. (PMID:19493002)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioopn1lw2ENSDARG00000044861
danio_rerioopn1lw1ENSDARG00000044862
mus_musculusOpn1mwENSMUSG00000031394
rattus_norvegicusOpn1mwENSRNOG00000051529

Paralogs (9): OPN3 (ENSG00000054277), OPN1LW (ENSG00000102076), OPN4 (ENSG00000122375), OPN5 (ENSG00000124818), OPN1SW (ENSG00000128617), RHO (ENSG00000163914), RRH (ENSG00000180245), OPN1MW (ENSG00000268221), OPN1MW3 (ENSG00000269433)

Protein

Protein identifiers

Medium-wave-sensitive opsin 2P0DN77 (reviewed: P0DN77)

Alternative names: Green cone photoreceptor pigment, Green-sensitive opsin, Opsin 1 cone pigments medium-wave-sensitive 2

All UniProt accessions (2): P0DN77, H0Y642

UniProt curated annotations — full annotation on UniProt →

Function. Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal.

Subcellular location. Cell membrane.

Post-translational modifications. N-glycosylated. O-glycosylated. Phosphorylated on some or all of the serine and threonine residues present in the C-terminal region.

Similarity. Belongs to the G-protein coupled receptor 1 family. Opsin subfamily.

RefSeq proteins (1): NP_001041646* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000276GPCR_RhodpsnFamily
IPR000378Opsin_red/grnFamily
IPR001760OpsinFamily
IPR017452GPCR_Rhodpsn_7TMDomain
IPR027430Retinal_BSBinding_site
IPR050125GPCR_opsinsFamily

Pfam: PF00001

UniProt features (21 total): topological domain 8, transmembrane region 7, region of interest 2, chain 1, modified residue 1, glycosylation site 1, disulfide bond 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0DN77-F182.820.56

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 312

Disulfide bonds (1): 126–203

Glycosylation sites (1): 34

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 41 (showing top): GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_PHOTOTRANSDUCTION, GOBP_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS, GOBP_REGULATION_OF_CELL_DIVISION, GOBP_RESPONSE_TO_RADIATION, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS

GO Biological Process (8): G protein-coupled receptor signaling pathway (GO:0007186), visual perception (GO:0007601), phototransduction (GO:0007602), absorption of visible light (GO:0016038), positive regulation of cytokinesis (GO:0032467), cellular response to light stimulus (GO:0071482), signal transduction (GO:0007165), detection of visible light (GO:0009584)

GO Molecular Function (3): G protein-coupled photoreceptor activity (GO:0008020), G protein-coupled receptor activity (GO:0004930), photoreceptor activity (GO:0009881)

GO Cellular Component (4): photoreceptor outer segment (GO:0001750), plasma membrane (GO:0005886), photoreceptor disc membrane (GO:0097381), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
G protein-coupled receptor activity2
signal transduction2
detection of light stimulus2
cellular anatomical structure2
sensory perception of light stimulus1
light absorption1
cytokinesis1
regulation of cytokinesis1
positive regulation of cell division1
positive regulation of cell cycle process1
response to light stimulus1
cellular response to radiation1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
detection of visible light1
photoreceptor activity1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
signaling receptor activity1
photoreceptor cell cilium1
membrane1
cell periphery1
photoreceptor outer segment1
organelle membrane1

Protein interactions and networks

STRING

346 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
OPN1MW2TEX28O15482507
OPN1MW2GUCA1CO95843502
OPN1MW2CRYAAP02489444
OPN1MW2OR51D1Q8NGF3430
OPN1MW2GNAT2P19087417
OPN1MW2OR52J3Q8NH60373
OPN1MW2GRAPLQ8TC17350
OPN1MW2CCDC66A2RUB6348
OPN1MW2NR2E3Q9Y5X4312
OPN1MW2GNAT1P11488291
OPN1MW2SEC61A2Q9H9S3287
OPN1MW2ARR3P36575284
OPN1MW2VSX1Q9NZR4283
OPN1MW2TMX3Q96JJ7272
OPN1MW2RCVRNP35243263

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: O12948, O18910, O18912, O18913, O18914, O35476, O35478, O35599, O57605, O93441, O93459, P04000, P04001, P0DN77, P0DN78, P22329, P22330, P22331, P22332, P22671, P28683, P32309, P32310, P32311, P32312, P32313, P34989, P35357, P35358, P41591, P41592, P51471, P51472, P51474, P51488, P79863, P87365, P87366, P87367, Q8AYM7

Diamond homologs: O12948, O13092, O13227, O18910, O18911, O18912, O18913, O18914, O35476, O35478, O35599, O42604, O57605, O62794, O93441, O93459, P03999, P04000, P04001, P0DN77, P0DN78, P22328, P22329, P22330, P22331, P22332, P22671, P28683, P28684, P32308, P32309, P32310, P32311, P32312, P32313, P34989, P35357, P35358, P35359, P35403

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

30 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic3
Likely pathogenic0
Uncertain significance19
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (3)

Variant IDHGVSClassification
1526876GRCh37/hg19 Xq28(chrX:153113943-153624020)Pathogenic
441742GRCh37/hg19 Xq28(chrX:153097608-153681801)x2Pathogenic
536592NC_000023.10:g.(?153295726)(153786885_?)dupPathogenic

SpliceAI

899 predictions. Top by Δscore:

VariantEffectΔscore
X:154219925:GAG:Gdonor_gain1.0000
X:154219926:AGG:Adonor_loss1.0000
X:154219927:GGT:Gdonor_loss1.0000
X:154219928:GTGA:Gdonor_loss1.0000
X:154227190:A:AGacceptor_gain1.0000
X:154227191:G:GGacceptor_gain1.0000
X:154227357:GCAG:Gdonor_gain1.0000
X:154227358:CAG:Cdonor_loss1.0000
X:154227358:CAGGT:Cdonor_loss1.0000
X:154227359:AGG:Adonor_loss1.0000
X:154227360:GGTA:Gdonor_loss1.0000
X:154227361:G:Adonor_loss1.0000
X:154227362:T:Gdonor_loss1.0000
X:154228822:CTCCA:Cacceptor_loss1.0000
X:154228823:TCCA:Tacceptor_loss1.0000
X:154228823:TCCAG:Tacceptor_loss1.0000
X:154228824:CCA:Cacceptor_loss1.0000
X:154228825:CA:Cacceptor_loss1.0000
X:154228825:CAG:Cacceptor_loss1.0000
X:154228826:AGGT:Aacceptor_loss1.0000
X:154228826:AGGTA:Aacceptor_loss1.0000
X:154228827:G:GTacceptor_loss1.0000
X:154228991:GCG:Gdonor_gain1.0000
X:154230545:TAGGT:Tacceptor_loss1.0000
X:154230785:CAGGT:Cdonor_loss1.0000
X:154230787:GGTA:Gdonor_loss1.0000
X:154230787:GGTAA:Gdonor_loss1.0000
X:154230788:GT:Gdonor_loss1.0000
X:154230788:GTA:Gdonor_loss1.0000
X:154230789:T:Gdonor_loss1.0000

AlphaMissense

2391 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1065427 (X:154230623 G>A), RS1065430 (X:154230626 C>T), RS1065432 (X:154230628 G>T), RS1065433 (X:154230631 A>C,G), RS1065434 (X:154230633 T>A), RS1065436 (X:154230638 T>C,G), RS1065437 (X:154230652 C>A,T), RS1065438 (X:154230656 G>A), RS112842419 (X:154223865 G>T), RS112920784 (X:154224227 G>A), RS113348300 (X:154218538 G>T), RS1196431422 (X:154217788 T>A), RS1219012335 (X:154218027 T>A,G), RS1260349389 (X:154218006 C>A), RS1273502906 (X:154218033 G>A)

Disease associations

OMIM: gene `` | disease phenotypes: MIM:300049, MIM:304120, MIM:309350, MIM:305620, MIM:300673

GenCC curated gene-disease

Mondo (5): heterotopia, periventricular, X-linked dominant (MONDO:0010233), otopalatodigital syndrome type 2 (MONDO:0010571), Melnick-Needles syndrome (MONDO:0010650), frontometaphyseal dysplasia (MONDO:0015942), severe neonatal-onset encephalopathy with microcephaly (MONDO:0010397)

Orphanet (7): Frontometaphyseal dysplasia (Orphanet:1826), Nodular neuronal heterotopia (Orphanet:2149), Melnick-Needles syndrome (Orphanet:2484), OBSOLETE: Otopalatodigital syndrome (Orphanet:669), Ehlers-Danlos syndrome with periventricular heterotopia (Orphanet:82004), Otopalatodigital syndrome type 2 (Orphanet:90652), MECP2-related severe neonatal encephalopathy (Orphanet:209370)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST90002381_504Eosinophil count2.000000e-11
GCST90002382_524Eosinophil percentage of white cells1.000000e-17

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004842eosinophil count
EFO:0007991eosinophil percentage of leukocytes

MeSH disease descriptors (3)

DescriptorNameTree numbers
C566878Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations (supp.)
C538064Frontometaphyseal dysplasia (supp.)
C538089Oto-palato-digital syndrome, type 2 (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyrenedecreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

6 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT05857085PHASE4COMPLETEDNovel Therapeutics and Endothelial Dysfunction in T1DM Patients
NCT06547216PHASE2ACTIVE_NOT_RECRUITINGPhase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05747924PHASE1/PHASE2COMPLETEDPhase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT01862146Not specifiedCOMPLETEDArterial Remodeling in Smokers
NCT02127333Not specifiedCOMPLETEDRole of Oxygen for Vascular Dysfunction
NCT04199949Not specifiedCOMPLETEDEffects of Five Days of Physical Inactivity on Endothelial Function in Healthy Humans